Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2975 (LINC02975) is a human long intergenic non-coding RNA gene classified within the family of lincRNAs, which are non-protein-coding RNAs longer than 200 nucleotides that do not overlap with protein-coding genes[1][3][7]. LincRNAs in general are involved in functions such as chromatin remodeling, transcriptional regulation, RNA stabilization, and can act as enhancers or regulators of neighboring genes[3][5]. While lincRNAs as a class can play roles in development, cellular differentiation, and disease, including cancer, there is no evidence that LINC02975 is a therapeutic target, nor are there drugs directly targeting it, and no clinical biomarker or safety concerns are reported for this molecule[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2975 (LINC02975).